A number of different studies have shown that neurotrophins, including nerve growth factor (NGF) support the survival of retinal ganglion neurons during a variety if insults. Recently, we have reported that that eye NGF administration can protect also photoreceptor degeneration in a mice and rat with inherited retinitis pigmentosa. However, the evidence that NGF acts directly on photoreceptors and that other retinal cells mediate the NGF effect could not be excluded. In the present study we have isolated retinal cells from rats with inherited retinitis pigmentosa (RP) during the post-natal stage of photoreceptor degenerative. In presence of NGF, these cells are characterized by enhanced expression of NGF-receptors and rhodopsin, the specific marker of photoreceptor and better cell survival, as well as neuritis outgrowth. Together these observations support the hypothesis that NGF that NGF acts directly on photoreceptors survival and prevents photoreceptor degeneration as previously suggested by in vivo studies.
Introduction
Animal models are widely used for investigating the aetiology of Retinitis Pigmentosa (RP) and ultimately for the developing a therapy for the disease [1] . The first animal model of inherited RP (RP) indicating the major characteristics of the human disease is the Royal College of Surgeon (RCS) rat. The visual pathogenesis of this rodent strain comprises a group of inherited progressive retinal cell dystrophies characterized by rod and cone photoreceptor degeneration, leading to progressive loss of vision [2, 3] . This eye pathology affects approximately 1 in 400 in a general population and currently a resolute therapy that can arrest or significantly modify the outcome of the disease is not available [4, 5] . Thus, any animals models of RP with similar genetic deficits, either occurring naturally or obtained through transgenic manipulations that can provide further information and allow to identify new mechanisms and hopefully suggest potential therapeutic strategies represent a major aim of numerous expert in this field of ocular disorder. The RCS rat is a well-known genetic animal model of photoreceptor degeneration to investigate this aspect, including the identification of biological mediator involved in mechanism of cell death and cell survival. During last few decades, fields of interest of these experimental approaches, include the use of drugs delivery [6] transplantation of retinal pigment epithelium (RPE) or photoreceptors [7] [8] [9] [10] , gene therapy [11] , the administration of growth factors [12] . The first evidence of possible neuroprotective effect of growth factor on retinal cell degeneration was reported by [12, 13] who demonstrated that beta-fibroblast growth factor might be able to protect degenerating photoreceptors in RCS rats [14] . Unfortunately, it was also found that this growth factor triggers retinal neovascularization making unacceptable for further studies and potential human therapy [14] . More recently, it was reported that retina of mice and rats affected with RP are characterized by reduced presence of Nerve Growth Factor (NGF) and NGF-receptors and suggested that exogenous NGF administration might delay and/or protect photoreceptors degeneration [15] [16] [17] [18] . Other studies supporting the hypothesis that NGF is involved in the protection of retinal cells were provided by Siliprandi et al in rat [19] Carmignoto et al in rabbit [20] , and in glaucoma by Lambiase and Aloe in rats and humans [21] .
Nerve growth factor (NGF) is the first discovered and the best characterized member of the neurotrophin family [22] that includes Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3/4/5 [23, 24] . The biological effect of NGF is mediated by two distinct receptors: trkA NGFR (a tyrosine kinase receptors) and p75 NTR and the biological activity on target cells depends on their surface trkA NGFR /p75 NTR ratio [25, 26] . Intracerebral administration of purified NGF has been shown to protect basal forebrain cholinergic neurons that are known to degenerate in brain aging and memory loss in laboratory animals [27, 28] and in Alzheimer's disease [29] . The neuroprotective role of NGF was furthermore suggested by our studies showing that in vivo NGF administration protects degenerating retinal ganglion cells and photoreceptors degeneration [18, 21, 30] 
Materials and Methods Ethics Statement and Animals
A total of 96 RCS animals at postnatal day 10 (p10) were housed at the CNR animal facility and handled according to the experimental procedure approved by the Ethical Commission on animal experimentation of the National Research Council (CNR, Rome). All experiments were conducted in accordance with the guidelines for the use of animals stated by the Association for Research in Vision and Ophthalmic Research. All efforts were made to reduce the total number of animals and to minimize animal suffering. At the time of sampling, animals were sacrificed by means of an overdose of anaesthetic (Ketamine-xylazine and tiletamine-zolazepam; Fort Dodge Veterinaria, S.A., Vall de Bianya-Girona, Spain).
Chemicals
NGF and neutralizing anti-NGF antibodies. NGF was purified in our laboratory from adult male mouse submaxillary glands, following the slightly modified method originally described by Bocchini and Angeletti in 1969 [31] . The anti-NGF antibody (ANA) was raised in goat and purified following the procedure indicated by Stoeckel and coworkers [32] . [33] . Photoreceptor purity (~80-90%) was verified by flow cytometry (MACSQuant Analyzer; Miltenyi, GmBH, Germany).
Biochemical analysis
Confocal microscopy. Fixed monolayers were incubated for 18hrs at 4°C with Rhodopsin antibody alone (single-staining; 1:300 diluted) or in combination with trkA NGFR or p75 NTR antibodies (double staining; 1:100 diluted). To assess for staining specificity, parallel sections were incubated with purified non-specific rabbit IgG antibodies (isotype; Vector, Burlingame, CA, USA). After appropriate washing, the slides were incubated with Alexa Fluor-488 goat anti-rabbit and/or Alexa Fluor-594 anti-specie-specific IgG secondary antibodies (1:400) for 1hr at room temperature. Nuclear counterstaining was performed with DAPI (0.1mM; Molecular Probes, Eugene, OR, USA). Sections were mounted in home-made anti-fading medium, observed under a confocal microscope (CLSM; SP5 Leica Microsystems; Wetzlar, Germany) and acquired at X60/objective (1024x1024 pixels; 10Hz acquisition speed; 30 or 60 μm pinehole and low/high laser exposure). No intensity-image adjustment was performed while for presentation purposes color-image changes were performed after assembling in panels (Adobe Photoshop ver.7; Adobe System, San Jose, CA, USA). Western Blot analysis. Pooled retinas (n = 5 pools/6 retinas for each pool) and untreated as well as NGF-exposed retinal cells or photoreceptors were homogenized in loading buffer (0.1M tris-HCl buffer, pH 6.8, containing 0.2M DTT, 4% SDS, 20% glycerol and 0.1% bromophenol blue), separated by 8% or 12% SDS-PAGE (20μL/lane) and transferred (18hrs/4°C) to PVDF membrane (GE Healthcare Bio-Sciences, Pittsburgh, USA). Membranes were incubated for 1hr at room temperature with a blocking buffer (5% non-fat dry milk in TBST: 10mM Tris, pH 7.5, 100mM NaCl and 0.1% 
Molecular analysis
Relative real-time PCR. Total RNA was extracted from pooled retinas (n = 5 pools/6 retinas each one) or cultured cells with TRIfast (EuroClone), according to manufacturers' suggestions and resuspended in 10μL fresh RNase free water (Direct Q5, Millipore Corporation, Billerica, MA, USA). To eliminate any DNA contamination, total RNA samples were treated with RNase-free DNaseI, according to the supplier's protocol (2U/uL DNAse; AM-1907; Turbo DNA free kit; Ambion Ltd., Huntingdon, Cambridgeshire, UK). Total RNA samples were checked for RNA quantity/purity (>1.8; A280, Nanodrop A1000; Thermo Fisher Scientific Inc., Wilmington, USA) and for absence of RNA degradation (1% agarose gel; SaeKem LE-agarose; Lonza, Milan, Italy). Equivalent amounts of RNA (1μg) were used as template to generate cDNAs in a one-cycler programmable thermocycler (PeqLab Biotech, Erlangen, Germany), according to the IMPROM manufacturer's procedure (Promega, Madison, USA). The resulting cDNAs were amplified using the SYBR Green PCR core reagent kit (Applied Biosystems, Foster City, CA, USA) in an Opticon2 programmable thermocycler (MJ Research, Watertown, MA, USA), according to a standard procedure. Samples were amplified in duplicate and in parallel with negative controls (either without template or with mRNA as template). Cycle thresholds (Cts) were recorded during linear amplification and normalized to those of referring genes run in parallel (nCts = Ct target −Ct referring ). Averages were calculated from replicates and expressed as normalized Ct or as expression ratio of a normalized target with respect to referring gene expression (absolute fold changes), according to REST analysis. The specific primers and amplification profiles were according to previous studies [34] . Primer specificities were confirmed by single melting curves monitored during amplification and provided at the end of amplification by the Opticon2 software. PCR products were randomly tested for single-band amplification by 2.5% agarose gel separation (SaeKem LE-agarose; Lonza, Basel, Switzerland).
Statistical analysis
All experiments were performed in duplicate and provided as mean±SEM in the graphics. Unpaired Student t test analysis was performed using the StatView software (Abacus Concepts Inc., Barkley, CA, USA). A p-value 0.05 was considered significant. The REST/ANOVA-coupled analysis was carried out for molecular comparisons [35] .
Results

Preliminary observations
Previous studies have shown that in RCS rats, the degeneration of photoreceptors begins at the first post-natal week and continues until the photoreceptor outer nuclear layer disappears completely [16] . Therefore to verify the hypothesis of this study, we selected retinas from 10 day old rats (p10), when a significant number of these cells start respectively to degenerate, lose and die [36] . This photoreceptor reduction has been associated with a decrease of local NGF levels [16] .
NGF biological activity on PC12
First of all, both NGF biological activity and neutralizing anti-NGF antibody (ANA) activities were tested on PC12 cells [37] . PC12 were plated at 10.000 cell density in the presence of medium alone, NGF (50ng/mL) or ANA (500ng/mL). Stimulating/neutralizing activities were determined by evaluating respectively the promoting (50ng/ml NGF) or blocking (50ng/ml NGF pre-incubated with 500 ng/ml ANA) neuritis outgrowth activity on PC12 cultured over 6 days (6d). The results of this preliminary analysis is shown in Fig 1A and 1B respectively. The effect of NGF exposure on survival of p10 retinal cells Thereafter, we tested the effect of NGF on primary cultures obtained from p10 retinas dissected out, dissociated and plated for 12hrs or 6d depending on the experiment. As shown in Fig 2, the cells quickly adhered to the plate (A, time 0 or 12hrs) and some of those were Rhodopsin positive (red staining). These Rhodopsin positive cells showed few elongations. After 6d of culturing in medium alone, a reduced number of Rhodopsin positive cells was detected, as compared to the initial plating (A). Upon 6d NGF exposure (C), the Rhodopsin positive cell number was comparable to those of plating (A) and interestingly elongations occurred in most of the Rhodopsin positive cells. The effect is clearly visible if comparing NGF treated with untreated fields (Cvs.B). These observations indicated that NGF stimulates the survival of photoreceptors.
The effect of NGF on Rhodopsin positive neuritis outgrowth and trkA NGFR expression. To validate the specificity of NGF effect on these retinal cells, primary cultures were seeded/cultured over 6d in medium alone or supplemented with NGF, neutralizing anti-NGF antibodies (ANA) or NGF pre-incubated with ANA (ANA/NGF). The Fig 3 highlighted the specificity of the addition of exogenous NGF on survival and neuritis outgrowth of dissociated According to data illustrated in Figs 2 and 3, these NGF-exposed Rhodopsin positive cells (photoreceptor) survived over 6d of culturing, implying that unless daily supply of NGF is provided, they will degenerate. This hypothesis might be supported by the observation that these cells express trkA NGFR To corroborate the confocal data, retinal cell cultures were cultured in medium alone or supplements and after 6d of culturing, the cells were harvested, fixed and subjected to Rhodopsin-immunobased magnetic separation to provide single Photoreceptor analysis. A flow chart outlining the procedure and a plotter of Rhodopsin-bearing cells backgated on total retinal cells are depicted in Fig 5A and 5B respectively. Isolated photoreceptors (>90% purity) were probed with anti-Rhodopsin antibodies in combination with anti-trkA NGFR specific antibodies.
As shown in Fig 5, 
Discussion
The aim of the present study was to investigate whether photoreceptors isolated from retina of RCS rats with RP express NGF-receptors and are affected by direct NGF exposure. Photoreceptors were isolated from ten day-old rats (herein shorten as p10), based on our previous timecourse studies showing that photoreceptor degeneration in RCS begin during the second week of post-natal age [16, 17] . By the way, whether photoreceptors express NGF-receptors and whether NGF exerts a direct role on photoreceptors, are still open questions. As a main output of the study, photoreceptors isolated from retina of rats with RP express trkA NGFR and co-express trkA NGFR and rhodopsin as evaluated with immune-localization and western blot analyses. The observation that photoreceptors express both mRNA and protein specific for trkA NGFR is consistent with the hypothesis that NGF exerts a direct action on photoreceptors of rats with RP. The results also revealed that the direct exposure to NGF enhances the expression of both rhodopsin and trkA NGFR , implying a potential survival activity [26] . Finally, the fact that these effects are blocked by ANA and NGF/pre-incubated with ANA, that inhibit the biological activity of NGF, indicate that the effect of NGF is strictly dependent by NGF and not due to other factors released by retinal cells. These observations confirmed and extended previous in vivo findings that NGF can protect and delay photoreceptor degeneration [16, 18] .
NGF exposure also stimulated neuritis outgrowth in isolated photoreceptors, as detected by confocal analysis. It is worth mentioning that the neuritis outgrowth promotes neural plasticity by stimulating the formation of new neuronal pathways [38] as well as the neuronal recovery following ischemic/chemical injury within the visual, peripheral and central nervous systems [16, 17, 28] .
Corroborated by previous in vivo studies, all the above reported findings support the hypothesis of a protective NGF role in the mechanism of photoreceptor death [17, 18] .
One critical question raised by this protective action of NGF on photoreceptors is the mechanism through which NGF exerts this protective effect. It has been shown in a consistent number of NGF-target cells that by binding to trkA NGFR , NGF up-regulates Bcl-2, a well-known protein exerting a crucial role in protecting cell from apoptosis through a prevention of caspase activation [34, 37, [39] [40] [41] . Our data show that NGF exposed photoreceptors express high levels of Bcl2 and low levels of Bax, supporting the hypothesis that NGF prevents photoreceptor cell death trough anti-apoptotic mechanism(s). The protective effects of the exogenous presence of NGF reinforce this hypothesis. It is therefore possible that the reduced expression of NGF in the retinal photoreceptor layer of rat with RP might be a critical signal that leads progressively to photoreceptor degeneration. To support, it was previously reported that the retina synthesizes and releases NGF and it was hypothesized that exogenous NGF administration can delay and/or protects photoreceptor degeneration [15, 16, 18] . The herein presented data indicate that NGF acts directly of photoreceptor survival. To summarize, RP is a group of inherited ocular human disease in which photoreceptor degeneration leads to visual loss and eventually to blindness [1] . A number of findings published over the last two decades suggest that NGF, the first discovered and best characterized neurotrophic factor, is an endogenous neuroprotective molecule and a potential player in the pathogenesis not only for numerous peripheral and brain neurons, but also for visual cells, including damaged corneal cells retinal ganglion cells and photoreceptors [13, 42] . NGF takes part in the proliferation, differentiation and functional activity of human, rabbit and rat corneal and retinal cells [27, [43] [44] [45] . NGF biological activity is mediated by two distinct receptors (trkA NGFR and p75 NTR ) and strictly dependent on their cell surface expression ratio [25, 26, [46] [47] [48] . We previously described that intraocular or topical eye NGF administration can delay and protect retinal ganglion cells from degeneration [19] [20] [21] 30] . Indeed, we recently reported that intravitreal NGF injection protects RP photoreceptors from degeneration [13, [16] [17] [18] . Although these in vivo results seem to clearly support the hypothesis that NGF acts on degenerating photoreceptors, a clear demonstration of a direct NGF effect has not yet been provided. The present findings on cultures of RP photoreceptors represent the first evidence that NGF acts directly on these cells.
Taken together, these in vitro and previous in vitro/in vivo studies on NGF administration support the hypothesis that the purified NGF molecule represent a critical survival factor not only for RGC degeneration, as observed in Glaucoma and Maculopathy [21, 38] , but also for photoreceptor degeneration. The availability of human recombinant NGF might encourage pursuing further studies.
